The common targets of obesity, T2DM, and AS are estrogen receptor 2 (ESR2), androgen receptor (AR), CYP19A1, NR3C1, SRC, and arachidonate 5-lipoxygenase (ALOX5). This evidence concerns the gene ESR2 and obesity due to melanocortin 4 receptor deficiency.